Xuexue Wu
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Single-cell profiling reveals distinct populations of tumor-associated macrophages and metastatic tumor cells in breast cancer brain metastasis.
Journal: Cell death & disease
Published: October 24, 2025
Integrated morphological and phylogenomic analyses revealed a novel genus Paramicrotoena (Lamiaceae - Pogostemoneae) discovered in the Pan-Himalaya.
Journal: Molecular phylogenetics and evolution
Published: April 10, 2025
Development of a prognostic risk stratification model for HER2-positive breast cancer brain metastasis and its implications in guiding treatment decisions.
Journal: Scientific reports
Published: March 17, 2025
Efficacy and safety of trastuzumab deruxtecan in HER2-positive breast cancer patients with brain metastases after failure of pyrotinib-based therapy.
Journal: Scientific reports
Published: January 30, 2025
Phylogenomic analyses revealed widely occurring hybridization events across Elsholtzieae (Lamiaceae).
Journal: Molecular phylogenetics and evolution
Published: February 06, 2024
Efficacy and safety of pyrotinib and radiotherapy vs. pyrotinib-based therapy in patients with HER2+ breast cancer with brain metastasis: a retrospective cohort study.
Journal: Annals of translational medicine
Published: September 19, 2022
Clinical outcomes of tucidinostat-based therapy after prior CDK4/6 inhibitor progression in hormone receptor-positive heavily pretreated metastatic breast cancer.
Journal: Breast (Edinburgh, Scotland)
Published: September 13, 2022
An exploratory study on the checkout rate of circulating tumor cells and the prediction of efficacy of neoadjuvant therapy and prognosis in patients with HER-2-positive early breast cancer.
Journal: Frontiers in oncology
Published: June 11, 2022
Showing 1-9 of 9
Last Updated: 09/26/2026